PeopleofSuperintelligence

Builder

Zack Dvey-Aharon

Zack Dvey-Aharon is co-founder and CEO of AEYE Health, whose AI screens for diabetic retinopathy. He studied for a machine learning PhD at Tel Aviv University, where he developed a fascination with how the field could advance healthcare. In 2018 he and Danny Margalit formed the group that later became AEYE Health. The company's AI received FDA clearance for autonomous screening in November 2022 and for portable screening in April 2024. TIME named him to the 2024 TIME100 AI list.

Now at
AEYE Health
Works
11
Citations
206
h-index
7

Publication numbers from OpenAlex, as of 15 October 2026.

Timeline

  1. By 2018

    A machine learning PhD

    By 2018 he studies for a PhD in machine learning at Tel Aviv University, where he develops a fascination with how it can advance healthcare.

  2. 2018

    Co-founding AEYE Health

    In 2018 he turns to his friend Danny Margalit, a former founder of a large Israeli tech company, and together they form what later becomes AEYE Health.

  3. November 2022

    FDA clearance for autonomous screening

    In November 2022 the FDA clears AEYE Health's AI for autonomous screening for referable diabetic retinopathy.

  4. April 2024

    Portable screening cleared by FDA

    In April 2024 the FDA clears a fully autonomous AI for portable diabetic retinopathy screening, and AEYE Health announces the clearance.

  5. 2024

    Named to the TIME100 AI list

    In 2024 TIME names him to its annual TIME 100 AI list.

  6. As of October 2026

    Co-founder and CEO of AEYE Health

    He is co-founder and CEO of AEYE Health.

Sources and credits

Photo: We have no published photo of Zack Dvey-Aharon yet. Send us a free-licensed photo.

  1. Zack Dvey-Aharon, Ph.D., CEO and Co-Founder of AEYE Health – Interview Series – Unite.AI unite.ai. Checked 15 October 2026.
  2. AEYE Health receives FDA clearance for AI-based autonomous screening for referable diabetic retinopathy prnewswire.com. Checked 15 October 2026.
  3. AEYE Health receives FDA clearance for first ever fully autonomous AI for portable DR screening | Eye Care Network - Modern Retina ophthalmologytimes.com. Checked 15 October 2026.
  4. FDA clears first fully autonomous AI for portable diabetic retinopathy screening prnewswire.com. Checked 15 October 2026.
  5. News | AEYE Health aeyehealth.com. Checked 15 October 2026.
  6. TAU's DNA is about giving students access to people and asking questions | The Jerusalem Post jpost.com. Checked 15 October 2026.